Sponsored

Leading device-based efficacy: acne clearance with Aerolase Neo Elite

September Med Esthetics Spread (1)

Aerolase: the leader in acne therapy

Clinical research validates that the Aerolase Neo Elite® is the premier device for treating all severities of acne and oil skin tones while providing the most positive patient experience in terms of comfort and fast results.

  • 92% of respondents reported that Neo Elite was as effective or more effective than other energy device treatments.1
  • 82% consider a Neo Elite as effective or more effective than topical retinoids.1
  • 94% of respondents reported that patients or parents had mentioned positive changes in self-perception since the Neo Elite.1
  • 7 Avg treatments per week at $400 per tx with 100% to your practice.1

Image1

Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:VAG Laser2

Authors: Nazanin Saedi, MD, Thomas Griffin Jr, MD, Sara Kelly CMA

1. (2024), Abstracts. "Response of Acne Patients to Treatment with a 650-Microsecond, 1064-nm, Pulsed Nd:YAG Laser: A Survey of 50 Dermatologists." Surg Med, 56: S6-SI85. https://doi.org/10.1002/Ism.23782

2. (2024), Abstracts. "Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:YAG Laser." Surg Med, 56: S5-SI85. https://doi.org/10.1002/Ism.23782

Aerolase Neo Elite: revolutionizing acne treatment

Advanced Technology for Comprehensive Care

Innovative 650-Microsecond Technology:

The Aerolase Neo Elite® utilizes advanced 650-microsecond technology, allowing deep skin penetration to reduce sebum production, suppress inflammation, and destroy C. acnes bacteria. This effectively clears active acne and prevents future breakouts.

Comprehensive Acne Management:

The Neo Elite® treats mild to severe acne and its associated side effects, including inflammatory lesions, post-inflammatory hyperpigmentation (PIH), erythema, and acne scars. It also enhances collagen production, reducing scar visibility.

Image2Versatility Across Skin Types:

Suitable for all skin types, including skin of color, the Neo Elite® delivers safe, effective treatments without the risk of burns, making it an ideal option for diverse patient populations.

Combination with Traditional Therapies:

The Neo Elite® can be used alongside traditional acne treatments like topical retinoids, oral antibiotics, and Accutane, providing faster relief and enhancing overall treatment plans.

Patient and Practice Benefits:

High patient satisfaction is reported due to the immediate and noticeable results, pain-free experience, and minimal downtime.2 Neo Elite’s ease of use, safety, and no consumable costs also make it economically advantageous for dermatology practices.

Clinical Efficacy:

Clinical data supports the Neo having the highest clearance rate compared to other acne lasers,3,4 with an 87% reduction in lesions at 90 days post-treatment,2 with significant improvements in PIH, erythema, and acne scars. High patient compliance and satisfaction were noted, with 90% satisfaction after three treatments.2

Additional Applications:

Beyond acne, the Neo Elite® effectively treats various skin conditions, offering a broad treatment palette and positive return on investment due to its versatility and cost-effectiveness.

I love it for that indication [treating PIH secondary to acne], it works well for residual active acne or residual PIH. We see reduced pigmentation and erythema after one treatment, which keeps patients coming back.

– Nazanin Saedi, MD

Image3

Qr

914.345.8300 | [email protected] | aerolase.com

@aerolase



1. LiVDerm. (n.d.). Acne awareness month: Common factors that exacerbate acne symptoms and minimize treatment efficacy. Retrieved from https://www.livderm.org/acne-awareness-month-common-factorsexacerbate-acne-symptoms-minimize-treatment-efficacy/2. (2024), Abstracts. "Treatment of Mild to Severe Acne Vulgaris with a 650-Microsecond 1064-nm Nd:YAG Laser." Surg Med, 56: S5-S185. https://doi.org/10.1002/lsm.23782.

3. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Cutera 510(K) K213461 letter, March 24, 2022, from https://www.accessdata.fda.gov/cdrh_docs/pdf21/K213461.pdf

4. Data on file, Accure Acne, Inc. https://accureacne.com/the-accure-acne-laser-system/

Disclaimer:

The above paid-for content was produced by and posted on behalf of the Sponsor. Content provided is generated solely by the Sponsor or its affiliates, and it is the Sponsor’s responsi­bility for the accuracy, completeness and validity of all information included. MedEsthetics takes steps to ensure that you will not confuse sponsored content with content produced by MedEsthetics and governed by its editorial policy.

More in Treatments